This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Oct;48(10):1580-2.

doi: 10.2967/jnumed.107.042911.

18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?

Wolfgang A Weber¹

Affiliations

PMID: 17909256
DOI: 10.2967/jnumed.107.042911

Free article

Comment

18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?

Wolfgang A Weber. J Nucl Med. 2007 Oct.

Free article

. 2007 Oct;48(10):1580-2.

doi: 10.2967/jnumed.107.042911.

Author

Wolfgang A Weber¹

Affiliation

¹ University of Freiburg, Freiburg, Germany. wolfgang.weber@uniklinik-freiburg.de

PMID: 17909256
DOI: 10.2967/jnumed.107.042911

No abstract available

PubMed Disclaimer

Comment on

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.
Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M. Lin C, et al. J Nucl Med. 2007 Oct;48(10):1626-32. doi: 10.2967/jnumed.107.042093. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873129

Similar articles

The role of FDG PET in the management of lymphoma: what is the evidence base?
Kirby AM, Mikhaeel NG. Kirby AM, et al. Nucl Med Commun. 2007 May;28(5):335-54. doi: 10.1097/MNM.0b013e3280895e23. Nucl Med Commun. 2007. PMID: 17414883 Review.
18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
Juweid ME. Juweid ME. J Nucl Med. 2008 Jan;49(1):9-12. doi: 10.2967/jnumed.107.046292. Epub 2007 Dec 12. J Nucl Med. 2008. PMID: 18077522 Review. No abstract available.
PET evaluation of lung cancer.
Bunyaviroch T, Coleman RE. Bunyaviroch T, et al. J Nucl Med. 2006 Mar;47(3):451-69. J Nucl Med. 2006. PMID: 16513615 Review. No abstract available.
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
Spaepen K, Mortelmans L. Spaepen K, et al. Q J Nucl Med. 2001 Sep;45(3):269-73. Q J Nucl Med. 2001. PMID: 11788819 Review.
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P, Sica S, Leone G. Chiusolo P, et al. Hematology. 2003 Dec;8(6):403-8. doi: 10.1080/1024533032000158841. Hematology. 2003. PMID: 14668036

See all similar articles

Cited by

Prognostic value of interim fluorodeoxyglucose and fluorothymidine PET/CT in diffuse large B-cell lymphoma.
Wang R, Xu B, Liu C, Guan Z, Zhang J, Li F, Sun L, Zhu H. Wang R, et al. Br J Radiol. 2018 Nov;91(1091):20180240. doi: 10.1259/bjr.20180240. Epub 2018 Jul 25. Br J Radiol. 2018. PMID: 30004787 Free PMC article.
18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.
Shelly MJ, McDermott S, O'Connor OJ, Blake MA. Shelly MJ, et al. ISRN Hematol. 2012;2012:456706. doi: 10.5402/2012/456706. Epub 2012 Mar 11. ISRN Hematol. 2012. PMID: 22474590 Free PMC article.
Relationship Between Dual Time Point FDG PET/CT and Clinical Prognostic Indexes in Patients with High Grade Lymphoma: a Pilot Study.
Lim DH, Lee JH. Lim DH, et al. Nucl Med Mol Imaging. 2017 Dec;51(4):323-330. doi: 10.1007/s13139-017-0480-y. Epub 2017 Apr 10. Nucl Med Mol Imaging. 2017. PMID: 29242726 Free PMC article.
Multi-observation PET image analysis for patient follow-up quantitation and therapy assessment.
David S, Visvikis D, Roux C, Hatt M. David S, et al. Phys Med Biol. 2011 Sep 21;56(18):5771-88. doi: 10.1088/0031-9155/56/18/001. Epub 2011 Aug 16. Phys Med Biol. 2011. PMID: 21846937 Free PMC article.
The evolving role of response-adapted PET imaging in Hodgkin lymphoma.
Coyle M, Kostakoglu L, Evens AM. Coyle M, et al. Ther Adv Hematol. 2016 Apr;7(2):108-25. doi: 10.1177/2040620715625615. Ther Adv Hematol. 2016. PMID: 27054026 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical
- MedlinePlus Health Information